FindTrial
Sign In

Medication adherence and QOL in patients with Diabetic peripheral Neuropathy

Pharmacotherapy, Medication Adherence and Quality of Life among Patients with Diabetic Peripheral Neuropathy in a tertiary care hospital- A prospective observational study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034642
Enrollment
200
Registered
2021-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All consenting adult patients with Type2 Diabetes according to the ADA criteria having Diabetic Peripheral Neuropathy

Exclusion criteria

Exclusion criteria: Patients who are critically ill - Patients with cognitive impairment - Patients who refuse for follow up

Design outcomes

Primary

MeasureTime frame
Assess the rates of adherence to Diabetic Peripheral Neuropathy medicationsTimepoint: 3 months from the baseline—

Secondary

MeasureTime frame
1.Determine the factors associated with Non-Adherence 2. Compare the quality of life between adherent and non-adherent group of patients at 3 months. 3. Study the pattern of drug use in Diabetic Peripheral NeuropathyTimepoint: 0 and 3 months—

Countries

India

Contacts

Public ContactShifra S

St.Johns Medical college

p_nidhin@hotmail.com09844353460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026